Preview

Атеросклероз

Расширенный поиск

Механизмы кардиопротективных эффектов средиземноморской диеты

https://doi.org/10.15372/ATER20180205

Аннотация

Обзор литературы посвящен анализу кардиопротективных механизмов средиземноморской диеты. Последние десятилетия средиземноморская диета является предметом изучения кардиологов всего мира. Многочисленные исследования подтвердили положительное влияние данного стереотипа питания на липидный профиль, массу тела, углеводный обмен, артериальное давление и сердечно-сосудистую заболеваемость в целом. В связи с этим вопрос патофизиологических влияний данного стереотипа питания на кардиоваскулярную систему является актуальным.

Об авторах

Д. П. Цыганкова
ФГБНУ НИИ комплексных проблем сердечно-сосудистых заболеваний; ФГБОУ ВО Кемеровский государственный медицинский университет Минздрава России
Россия


К. Е. Кривошапова
ФГБНУ НИИ комплексных проблем сердечно-сосудистых заболеваний
Россия


Список литературы

1. Menotti A., Puddu P.E. How the Seven Countries Study contributed to the definition and development of the Mediterranean diet concept: a 50-year journey // Nutr. Metab. Cardiovasc. Dis. 2015. Vol. 25, N 3. P. 245-252.

2. Martínez-González M.A., Salas-Salvadó J., Estruch R. et al. Benefits of the mediterranean diet: insights from the PREDIMED Study // Prog. Cardiovasc. Dis. 2015. Vol. 58, N 1. P. 50-60.

3. Ros E., Martínez-González M.A., Estruch R. et al. Mediterranean diet and cardiovascular health: Teachings of the PREDIMED study // Adv. Nutr. 2014. Vol. 5, N 3. P. 330-336.

4. De Lorgeril M., Salen P., Martin J.L. et al. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study // Circulation. 1999. Vol. 99, N 6. P. 779-785.

5. Widmer R.J., Flammer A.J., Lerman L.O., Lerman A. The mediterranean diet, its components, and cardiovascular disease // Am. J. Med. 2015. Vol. 128, N 3. P. 229-238.

6. Romagnolo D.F., Selmin O.I. Mediterranean diet and prevention of chronic diseases // Nutrition Today. 2017. Vol. 52, N 5. P. 208-222.

7. Gerber M., Hoffman R. The Mediterranean diet: health, science and society // Br. J. Nutr. 2015. Vol. 113. P. 4-10.

8. Cade J., Upmeier H., Calvert C., Greenwood D. Costs of a healthy diet: analysis from the UK women’s cohort study // Public. Health Nutr. 1999. Vol. 2. P. 505-512.

9. Saulle R., Semyonov L., La Torre G. Cost and cost-effectiveness of the mediterranean diet: results of a systematic review // Nutrients. 2013. Vol. 5, N 11. P. 4566-4586.

10. Marin C., Ramirez R., Delgado-Lista J. et al. Mediterranean diet reduces endothelial damage and improves the regenerative capacity of endothelium // Am. J. Clin. Nutr. 2011. Vol. 93, N 2. P. 267-274.

11. Bellido C., López-Miranda J., Blanco-Colio L.M. et al. Butter and walnuts, but not olive oil, elicit postprandial activation of nuclear transcription factor kappaB in peripheral blood mononuclear cells from healthy men // Am. J. Clin. Nutr. 2004. Vol. 80, N 6. P. 1487-1491.

12. Widmer R., Freund M.A., Flammer A.J. et al. Beneficial effects of polyphenol-rich olive oil in patients with early atherosclerosis // Eur. J. Nutr. 2013. Vol. 52, N 3. P. 1223-1231.

13. Mensink R., Katan M.B. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials // Arterioscler. Thromb. 1992. Vol. 12, N 8. P. 911-919.

14. Silva S., Bronze M.R., Figueira M.E. et al. Impact of a 6-wk olive oil supplementation in healthy adults on urinary proteomic biomarkers of coronary artery disease, chronic kidney disease, and diabetes (types 1 and 2): a randomized, parallel, controlled, double-blind study // Am. J. Clin. Nutr. 2015. N 101. P. 44-54.

15. Santangelo C., Filesi C., Varì R. et al. Consumption of extra-virgin olive oil rich in phenolic compounds improves metabolic control in patients with type 2 diabetes mellitus: a possible involvement of reduced levels of circulating visfatin // J. Endocrinol. Invest. 2016. N 39. P. 1295-1301.

16. Estruch R., Martínez-González M.A., Corella D. et al. Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial // Ann. Int. Med. 2006. N 145. P. 1-11.

17. Salas-Salvadó J., Bulló M., Estruch R. et al. Prevention of diabetes with Mediterranean diets: a subgroup analysis of a randomized trial // Ann. Int. Med. 2014. N 160. P. 1-10.

18. Estruch R., Martínez-González M.A., Corella D. et al. Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial // Ann. Int. Med. 2006. N 145. P. 1-11.

19. Lasa A., Miranda J., Bulló M. et al. Comparative effect of two Mediterranean diets versus a low-fat diet on glycaemic control in individuals with type 2 diabetes // Eur. J. Clin. Nutr. 2014. N 68. P. 767-772.

20. Guasch-Ferré M., Merino J., Sun Q. et al. Dietary polyphenols, mediterranean diet, prediabetes, and type 2 diabetes: a narrative review of the evidence // Oxidat. Med. and Cell. Long. 2017. N 2017. P. 6723931.

21. Balk E.M., Lichtenstein A.H., Chung M. et al. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review // Atherosclerosis. 2006. Vol. 189, N 1. P. 19-30.

22. Harris W.S., Connor W.E., Illingworth D.R. et al. Effects of fish oil on VLDL triglyceride kinetics in humans // J. Lipid. Res. 1990. N 31. P. 1549-1558.

23. Nestel P.J., Connor W.E., Reardon M.F. et al. Suppression by diets rich in fish oil of very low density lipoprotein production in man // J. Clin. Invest. 1984. N 74. P. 82-89.

24. Park Y., Harris W.S. Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance // J. Lipid. Res. 2003. N 44. P. 455-463.

25. Mori T.A., Beilin L.J. Omega-3 fatty acids and inflammation // Curr. Atheroscler. Rep. 2004. N 6. P. 461-781.

26. Mente A., de Koning L., Shannon H.S. et al. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease // Arch. Int. Med. 2009. Vol. 169, N 7. P. 659-669.

27. Hu F., Manson J.E., Willett W.C. Types of dietary fat and risk of coronary heart disease: a critical review // J. Am. Coll. Nutr. 2001. Vol. 20, N 1. P. 5-19.

28. Hu F., Stampfer M.J. Nut consumption and risk of coronary heart disease: a review of epidemiologic evidence // Curr. Atheroscler. Rep. 1999. Vol. 1, N 3. P. 204-209.

29. Banel D., Hu F.B. Effects of walnut consumption on blood lipids and other cardiovascular risk factors: a meta-analysis and systematic review // Am. J. Clin. Nutr. 2009. Vol. 90, N 1. P. 56-63.

30. Kelly R. Diet and exercise in the management of hyperlipidemia // Am. Fam. Phys. 2010. Vol. 81, N 9. P. 1097-1102.

31. Casas-Agustench P., Lopez-Uriarte P., Bullo M. et al.

32. Effects of one serving of mixed nuts on serum lipids, insulin resistance and inflammatory markers in patients with the metabolic syndrome // Nutr. Metabol. Cardiovasc. Dis. 2011. N 21. P. 126-135.

33. Luo C., Zhang Y., Ding Y. et al. Nut consumption and risk of type 2 diabetes, cardiovascular disease, and all-cause mortality: a systematic review and meta-analysis // Am. J. Clin. Nutr. 2014. N 100. P. 256-269.

34. Kang I., Buckner T., Shay N.F. et al. Improvements in metabolic health with consumption of Ellagic acid and subsequent conversion into urolithins: evidence and mechanisms // Advances in Nutrition: Int. Rev. J. 2016. N 7. P. 961-972.

35. Graham I., Atar D., Borch-Johnsen K. et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts) // Eur. Heart J. 2007. Vol. 28, N 19. P. 2375-2414.

36. Lichtenstein A., Appel L.J., Brands M. et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee // Circulation. 2006. Vol. 114, N 1. P. 82-96.

37. Beitz R., Mensink G.B.M., Fischer B. Blood pressure and vitamin C and fruit and vegetable intake // Ann. Nutr. Metabol. 2003. N 47. P. 214-220.

38. Alonso A., de la Fuente C., Martín-Arnau A.M. et al. Fruit and vegetable consumption is inversely associated with blood pressure in a Mediterranean population with a high vegetable-fat intake: the Seguimiento Universidad de Navarra (SUN) Study // Brit. J. Nutr. 2004. N 92. P. 311-319.

39. Lin B., Morrison R.M. Higher fruit consumption linked with lower body mass index // Food Review. 2002. N 25. P. 28-32.

40. Dauchet L., Amouyel P., Hercberg S. et al. Fruit and vegetable consumption and risk of coronary heart disease: a meta-analysis of cohort studies // J. Nutr. 2006. Vol. 136, N 10. P. 2588-2593.

41. He F., Nowson C.A., Lucas M., MacGregor G.A. Increased consumption of fruit and vegetables is related to a reduced risk of coronary heart disease: meta-analysis of cohort studies // J. Hum. Hypertens. 2007. Vol. 21, N 9. P. 717-728.

42. Dauchet L., Amouyel P., Dallongeville J. Fruits, vegetables and coronary heart disease // Nat. Rev. Cardiol. 2009. Vol. 6, N 9. P. 599-608.

43. Crowe F., Roddam A.W., Key T.J. et al. Fruit and vegetable intake and mortality from ischaemic heart disease: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Heart study // Eur. Heart J. 2011. Vol. 32, N 10. P. 1235-1243.

44. Van Horn L. Fiber, lipids, and coronary heart disease. A statement for healthcare professionals from the Nutrition Committee, American Heart Association // Circulation. 1997. Vol. 95, N 12. P. 2701-2704.

45. Katcher H., Legro R.S., Kunselman A.R. et al. The effects of a whole grain-enriched hypocaloric diet on cardiovascular disease risk factors in men and women with metabolic syndrome // Am. J. Clin. Nutr. 2008. Vol. 87, N 1. P. 79-90.

46. Mellen P., Walsh T.F., Herrington D.M. Whole grain intake and cardiovascular disease: a meta-analysis // Nutr. Metab. Cardiovasc. Dis. 2008. Vol. 18, N 4. P. 283-290.

47. Liu S., Stampfer M.J., Hu F.B. et al. Whole-grain consumption and risk of coronary heart disease: results from the Nurses Health Study // Am. J. Clin. Nutr. 1999. Vol. 70, N 3. P. 412-419.

48. Jacobs D.J., Meyer K.A., Kushi L.H. et al. Whole-grain intake may reduce the risk of ischemic heart disease death in postmenopausal women: the Iowa Women’s Health Study // Am. J. Clin. Nutr. 1998. Vol. 68, N 2. P. 248-257.

49. Jacobs D.R., Pereira M.A., Meyer K.A. et al. Fiber from whole grains, but not refined grains, is inversely associated with all-cause mortality in older women: the Iowa women’s health study // J. Am. Coll. Nutr. 2000. Vol. 19, N 3. Р. 326S-330S.

50. He M., van Dam R.M., Rimm E. et al. Whole-grain, cereal fiber, bran, and germ intake and the risks of all-cause and cardiovascular disease-specific mortality among women with type 2 diabetes mellitus // Circulation. 2010. Vol. 121, N. 20. P. 2162.

51. Anderson J., Baird P., Davis R.H. et al. Health benefits of dietary fiber // Nutr. Rev. 2009. Vol. 67, N 4. P. 188-205.

52. Dom K., Liu R.H. Antioxidant activity of grains // J. Agric. Food Chem. 2002. Vol. 50, N 21. P. 6182-6187.

53. Anderson J., Hanna T.J., Peng X. et al. Whole grain foods and heart disease risk // J. Am. Coll. Nutr. 2000. N 19. P. 291S-299S.

54. Jenkins D., Wesson V., Wolever T.M. et al. Wholemeal versus wholegrain breads: proportion of whole or cracked grain and the glycaemic response // BMJ. 1988. Vol. 297, N 6654. P. 958-960.

55. Tarini J., Wolever T.M. The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects // Appl. Physiol. Nutr. Metab. 2010. Vol. 35, N 1. P. 9-16.

56. Good C., Holschuh N., Albertson A.M., Eldridge A.L. Whole grain consumption and body mass index in adult women: an analysis of NHANES 1999-2000 and the USDA pyramid servings database // J. Am. Coll. Nutr. 2008. Vol. 27, N 1. P. 80-87.

57. Tresserra-Rimbau A., Guasch-Ferre M., Salas-Salvado J. et al. Intake of total polyphenols and some classes of polyphenols is inversely associated with diabetes in elderly people at high cardiovascular disease risk // J. Nutrition. 2016. Vol. 146. P. 767-777.

58. Sun Q., Wedick N.M., Pan A. et al. Gut microbiota metabolites of dietary lignans and risk of type 2 diabetes: a prospective investigation in two cohorts of U.S. women // Diabetes Care. 2014. N 37. P. 1287-1295.

59. Asu A., Betts N.M., Nguyen A., Newman et al. Freeze-dried strawberries lower serum cholesterol and lipid peroxidation in adults with abdominal adiposity and elevated serum lipids // J. Nutrition. 2014. N 144. P. 830-837.

60. Liu Z.-M., Chen Y.-M., Ho S.C. Effects of soy intake on glycemic control: a meta-analysis of randomized controlled trials // Am. J. Clin. Nutr. 2011. N 93. P. 1092-1101.

61. Ricci E., Cipriani S., Chiaffarino F. et al. Effects of soy isoflavones and genistein on glucose metabolism in perimenopausal and postmenopausal non-Asian women // Menopause. 2010. N 17. P. 1080-1086.

62. Rhee Y., Brunt A. Flaxseed supplementation improved insulin resistance in obese glucose intolerant people: a randomized crossover design // Nutr. J. 2011. N 10. P. 44.

63. Lemay A., Dodin S., Kadri N. et al. Flaxseed dietary supplement versus hormone replacement therapy in hypercholesterolemic menopausal women // Obstetrics and Gynecology. 2002. N 100. P. 495-504.

64. Pan A., Sun J., Chen Y. et al. Effects of a flaxseed-derived lignan supplement in type 2 diabetic patients: a randomized, double-blind, cross-over trial // PLoS One. 2007. N 2. P. e1148.

65. Pan A., Demark-Wahnefried W., Ye X. et al. Effects of a flaxseed-derived lignan supplement on C-reactive protein, IL-6 and retinol-binding protein 4 in type 2 diabetic patients // Br. J. Nutr. 2009. N 101. P. 1145.

66. Cornish S.M., Chilibeck P.D., Paus-Jennsen L. et al. A randomized controlled trial of the effects of flaxseed lignan complex on metabolic syndrome composite score and bone mineral in older adults // Appl. Physiol. Nutr. Metab. 2009. N 34. P. 89-98.

67. Caton P.W., Pothecary M.R., Lees D.M. et al. Regulation of vascular endothelial function by procyanidin-rich foods and beverages // J. Agric. Food Chem. 2010. Vol. 58, N. 7. P. 4008-4013.

68. Шамшева Д.С., Богданов А.Р. Кардиопротективные эффекты средиземноморской диеты // Креатив. кардиология. 2014. № 1. С. 57-63.

69. Zamora-Ros R., Forouhi N.G., Sharp S.J. et al. Dietary intakes of individual flavanols and flavonols are inversely associated with incident type 2 diabetes in European populations // J. Nutr. 2014. N 144. P. 335-343.

70. Eidelman R.S., Vignola P., Hennekens C.H. Alcohol consumption and coronary heart disease: a causal and protective factor // Seminars Vascular. Med. 2002. Vol. 2, N 3. P. 253-256.

71. Van Wormer J.J., Boucher J.L., Sidebottom A.C. et al. Lifestyle changes and prevention of metabolic syndrome in the Heart of New Ulm // Project Preventive Medicine Reports. 2017. Vol. 6. P. 242-245.

72. Grosso G., Marventano S., Yang J. et al. A comprehensive meta-analysis on evidence of Mediterranean diet and cardiovascular disease: Are individual components equal? // Crit. Rev. Food Sci. Nutr. 2017. Vol. 57, N 15. P. 3218-3232.

73. Mirmiran P., Moslehi N., Mahmoudof H. et al. A longitudinal study of adherence to the mediterranean dietary pattern and metabolic syndrome in a non-mediterranean population // Int. J. Endocrinol. Metab. 2015. N 13. P. e26128.

74. Alharbi K.K., Richardson T.G., Khan I.A. et al. Influence of adiposity-related genetic markers in a population of saudi arabians where other variables influencing obesity may be reduced // Dis. Markers. 2014. N 2014. P. 758232.

75. Consultation W.E. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies // Lancet. 2004. N 363. P. 157-163.

76. Hosseini-Esfahani F., Koochakpoor G., Daneshpour M.S.

77. et al. Mediterranean dietary pattern adherence modify the association between FTO genetic variations and obesity phenotypes // Nutrients. 2017. Vol. 9, N 10. P. 1064.

78. Konstantinidou V., Covas M.I., Sola R. et al. Up-to date knowledge on the in vivo transcriptomic effect of the Mediterranean diet in humans // Mol. Nutr. Food Res. 2013. N 57. P. 772-783.

79. Llorente-Cortés V., Estruch R., Mena M.P. et al. Effect of Mediterranean diet on the expression of pro-atherogenic genes in a population at high cardiovascular risk // Atherosclerosis. 2010. N 208. P. 442-450.

80. Konstantinidou V., Covas M.I., Muñoz-Aguayo D. et al. In vivo nutrigenomic effects of virgin olive oil polyphenols within the frame of the Mediterranean diet: A randomized controlled trial // FASEB J. 2010. N 24. P. 2546-2557.

81. Serrano-Martinez M., Palacios M., Martinez-Losa E. et al. A Mediterranean dietary style influences TNF-alpha and VCAM-1 coronary blood levels in unstable angina patients // Eur. J. Nutr. 2005. N 44. P. 348-354.

82. García-Calzón S., Martínez-González M.A., Razquin C.

83. et al. Pro12Ala polymorphism of the PPARg2 gene

84. interacts with a mediterranean diet to prevent telomere shortening in the PREDIMED-NAVARRA randomized trial // Circ. Cardiovasc. Genet. 2015. N 8. P. 91-99.

85. Fitó M., Konstantinidou V. Nutritional Genomics and the Mediterranean Diet’s Effects on Human Cardiovascular Health // Nutrients. 2016. Vol. 8, N 4. P. 218.


Рецензия

Для цитирования:


Цыганкова Д.П., Кривошапова К.Е. Механизмы кардиопротективных эффектов средиземноморской диеты. Атеросклероз. 2018;14(2):32-40. https://doi.org/10.15372/ATER20180205

For citation:


Tsygankova D.P., Krivoshapova K.E. Mechanisms of cardioprotective effects of the Mediterranean diet. Ateroscleroz. 2018;14(2):32-40. (In Russ.) https://doi.org/10.15372/ATER20180205

Просмотров: 230


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2078-256X (Print)
ISSN 2949-3633 (Online)